Physical health management in psychiatric settings

European Psychiatry : the Journal of the Association of European Psychiatrists
Marc De HertJoseph Peuskens

Abstract

Severe mental disorders have a chronic course associated with a high risk for co-morbid somatic illnesses and premature mortality, but despite this increased risk, general health care needs in this population are often neglected. Over recent years, several groups have developed screening and monitoring guidelines for metabolic and cardiovascular risk assessment in patients treated with antipsychotics. The psychiatrist needs to be aware of the potential metabolic side-effects of antipsychotic medication and to include them in the risk/benefit assessment when choosing a specific antipsychotic. He should also be responsible for the implementation of the necessary screening assessments and referral for treatment of any physical illness. Multidisciplinary assessment of psychiatric and medical conditions is needed. The somatic treatments offered to people with severe and enduring mental illness should be at par with general health care in the non-psychiatrically ill population. In our University Centre, a structured and elaborate screening and monitoring protocol was introduced in late 2003. This paper describes the practical aspects of this monitoring protocol and the results obtained 4 years after its implementation.

References

Mar 31, 1998·The British Journal of Psychiatry : the Journal of Mental Science·S Brown
Aug 27, 1999·The Journal of Nervous and Mental Disease·L DixonA Lehman
Sep 9, 2000·Schizophrenia Research·U OsbyP Sparén
Oct 21, 2000·The British Journal of Psychiatry : the Journal of Mental Science·S BrownB Barraclough
May 19, 2001·Australian and New Zealand Journal of Public Health·M L BoothS Mathur
Apr 2, 2002·The American Journal of Psychiatry·Michael J SernyakRobert Rosenheck
Jan 14, 2003·The Journal of Clinical Psychiatry·J Jaime CaroKimberly Robinson
Mar 29, 2003·Psychiatric Services : a Journal of the American Psychiatric Association·David B AllisonDiana D McDonnell
May 27, 2003·Schizophrenia Research·Martin StrassnigRohan Ganguli
Nov 25, 2003·The Annals of Pharmacotherapy·Leslie L Citrome, Ari B Jaffe
Dec 25, 2003·Schizophrenia Research·Peter J WeidenDiana D McDonnell
Jan 30, 2004·Diabetes Care·UNKNOWN American Diabetes AssociationUNKNOWN North American Association for the Study of Obesity
Jul 13, 2004·Schizophrenia Research·A George Awad, Lakshmi N P Voruganti
Aug 3, 2004·The American Journal of Psychiatry·Stephen R MarderSteven Shon
Sep 10, 2004·Journal of Clinical Psychopharmacology·John W NewcomerAntony D Loebel
Oct 12, 2004·Schizophrenia Research·Hua JinDilip V Jeste
Jun 21, 2005·Schizophrenia Research·Peter F BuckleyEdna M Stirewalt
Nov 11, 2005·Journal of Psychopharmacology·Leslie Citrome, David Yeomans
Dec 13, 2005·American Heart Journal·Charles H HennekensDaniel E Casey
Feb 14, 2006·Schizophrenia Bulletin·Faith B DickersonLisa B Dixon
Mar 7, 2006·Current Pharmaceutical Design·Sandra ShibuyamaJames D Scott
Apr 8, 2006·International Clinical Psychopharmacology·Hélène Verdoux, Audrey Cougnard
Jun 29, 2006·Clinical Practice and Epidemiology in Mental Health : CP & EMH·M De HertJ Peuskens
Jul 1, 2006·BMC Pulmonary Medicine·Demosthenes MakrisNikolaos M Siafakas
Jul 27, 2006·Journal of Psychiatric and Mental Health Nursing·E Muir-Cochrane
Aug 29, 2006·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Tony A Cohn, Michael J Sernyak
Aug 31, 2006·Schizophrenia Bulletin·Marc De HertJoseph Peuskens
Sep 26, 2006·Schizophrenia Research·Marc De HertJoseph Peuskens
Dec 30, 2006·The Journal of Clinical Psychiatry·Marc De HertJoseph Peuskens
Apr 7, 2007·Diabetes & Metabolism·A J Scheen, M A De Hert
Oct 9, 2007·Acta Psychiatrica Scandinavica·S LeuchtN Sartorius
Mar 29, 2008·The Journal of Clinical Psychiatry·W Wolfgang FleischhackerJeffrey A Lieberman

❮ Previous
Next ❯

Citations

Oct 24, 2012·European Journal of Clinical Pharmacology·H Abdullah-KoolmeesE R Heerdink
Mar 15, 2011·European Psychiatry : the Journal of the Association of European Psychiatrists·D VancampfortM De Hert
Jul 22, 2010·European Psychiatry : the Journal of the Association of European Psychiatrists·C Höschl
Jul 22, 2010·European Psychiatry : the Journal of the Association of European Psychiatrists·A HealdC U Correll
Jun 15, 2010·European Psychiatry : the Journal of the Association of European Psychiatrists·M De HertJ Peuskens
Dec 23, 2015·The Australian Journal of Rural Health·Susanne H StanleySivasankaran Balaratnasingam
Jun 3, 2011·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Marc De HertChristoph U Correll
Feb 20, 2013·Journal of Psychiatric and Mental Health Nursing·B HappellD Scott
Mar 3, 2015·European Psychiatry : the Journal of the Association of European Psychiatrists·W GaebelUNKNOWN European Psychiatric Association
Jun 22, 2016·Gaceta sanitaria·Montse BallbèUNKNOWN Tobacco and Mental Health Working Group
Jul 5, 2012·The Australian and New Zealand Journal of Psychiatry·Cherrie A GalletlyVera A Morgan
Jul 15, 2015·The Annals of Pharmacotherapy·Heshu Abdullah-KoolmeesEibert R Heerdink
Aug 1, 2014·The Annals of Pharmacotherapy·Heshu Abdullah-KoolmeesEibert R Heerdink
Jul 31, 2016·BMC Family Practice·Carianne M HuntAnne McBride
Jun 9, 2016·Biological Research for Nursing·Chiu-Yueh YangYing-Chieh Peng
Aug 5, 2017·Social Work in Health Care·Denise R Black, Mary L Held
Oct 7, 2017·International Journal of Psychiatry in Clinical Practice·Unax LertxundiJuan Medrano
Nov 7, 2019·Journal of Mental Health·Jentien M VermeulenLieuwe de Haan
Apr 2, 2013·International Journal of Epidemiology·Montse BallbèEsteve Fernández
May 13, 2017·Frontiers in Psychiatry·Angelo G I MaremmaniIcro Maremmani
Jul 24, 2020·BMJ Open Quality·Sarah Michael, Kirsty MacDonald
Feb 8, 2020·Administration and Policy in Mental Health·Torleif RuudGary R Bond

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

European Psychiatry : the Journal of the Association of European Psychiatrists
A-L Montejo
European Psychiatry : the Journal of the Association of European Psychiatrists
A HealdChristoph U Correll
European Psychiatry : the Journal of the Association of European Psychiatrists
C Höschl
European Psychiatry : the Journal of the Association of European Psychiatrists
Marc De HertJoseph Peuskens
© 2021 Meta ULC. All rights reserved